Section Arrow
AIMD.NASDAQ
- Ainos
  suspend
(Financial Status)
Quotes are at least 15-min delayed:2025/06/28 15:02 EDT
Last
 0.5
+0.0178 (+3.69%)
Day High 
0.5099 
Prev. Close
0.4822 
1-M High
0.8 
Volume 
262.86K 
Bid
0.4853
Ask
0.517
Day Low
0.48 
Open
0.48 
1-M Low
0.4531 
Market Cap 
10.11M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.51 
20-SMA 0.57 
50-SMA 0.56 
52-W High 1.07 
52-W Low 0.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.20/--
Enterprise Value
19.11M
Balance Sheet
Book Value Per Share
0.63
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
20.73K
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 15:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, andtelehealth-friendly POCTs powered by the AI Nose technology platform.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.